SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes

SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes

Gespeichert in:

Bibliographische Detailangaben
Datum:	2015
Hauptverfasser:	S. V. Chekhun, T. V. Zadvorny, Yu. O. Tymovska, M. F. Anikusko, O. E. Novak, L. Z. Polishchuk
Format:	Artikel
Sprache:	English
Veröffentlicht:	2015
Schriftenreihe:	Experimental Oncology
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0000409056
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: Chekhun, S.V., et al.
Veröffentlicht: (2015)

Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
von: Ryspayeva, D.E., et al.
Veröffentlicht: (2017)

Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
von: Yu. Lukianova, et al.
Veröffentlicht: (2017)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
von: S. M. Hrybach, et al.
Veröffentlicht: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
von: Ryspayeva, D.E.
Veröffentlicht: (2018)

Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
von: D. E. Ryspayeva
Veröffentlicht: (2018)

Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
von: Zavyalova, M., et al.
Veröffentlicht: (2016)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: Chekhun, S., et al.
Veröffentlicht: (2013)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: S. Chekhun, et al.
Veröffentlicht: (2013)

EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
von: L. M. Kovalevska, et al.
Veröffentlicht: (2019)

Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
von: Kropyvko, S.V., et al.
Veröffentlicht: (2019)

Stem cell therapy for hereditary breast cancer
von: Rassi, H.
Veröffentlicht: (2009)

Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
von: N. O. Verovkina, et al.
Veröffentlicht: (2017)

Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
von: I. P. Nesina, et al.
Veröffentlicht: (2019)

Research of stem tumor cells subpopulation on models of breast cancer
von: T. S. Herheliuk, et al.
Veröffentlicht: (2022)

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome
von: Timovska, Yu., et al.
Veröffentlicht: (2011)

Orally given chemo-endocrine therapy for patients with luminal Her-2/neu negative metastasing breast cancer
von: Yu. O. Tymovska, et al.
Veröffentlicht: (2016)

Epigenetics in breast cancer
von: Atalay, C.
Veröffentlicht: (2013)

Epigenetics in breast cancer
von: C. Atalay
Veröffentlicht: (2013)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Features of hepcidin expression in patients with breast cancer
von: Yu. Lukianova, et al.
Veröffentlicht: (2015)

Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
von: L. A. Nalieskina, et al.
Veröffentlicht: (2017)

Chromosomal Radiosensitivity in Ukrainian breast cancer patients and healthy Individuals
von: Ryabchenko, N.M., et al.
Veröffentlicht: (2012)

Prospects of the use of molecular markers in cancer of ovaries
von: A. A. Mikhanovskij, et al.
Veröffentlicht: (2015)

Breast cancer with diabetes insipidus
von: Dogan, M., et al.
Veröffentlicht: (2008)

The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
von: Liubota, R., et al.
Veröffentlicht: (2017)

Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
von: L. A. Nalieskina, et al.
Veröffentlicht: (2018)

Estimation of content of CD44+CD24– cells as additional criterion of efficiency of preventive therapy in experiment at oncopathology
von: N. A. Bondarovich, et al.
Veröffentlicht: (2008)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: V. F. Chekhun, et al.
Veröffentlicht: (2015)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: Shepil, O.V., et al.
Veröffentlicht: (2014)

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

The use of proteomic technologies in breast cancer research
von: Mazur, M.G., et al.
Veröffentlicht: (2016)

Staging, risk assessment and screening of breast cancer
von: Yalcin, B.
Veröffentlicht: (2013)

Immune checkpoint blockade in breast cancer therapy
von: I. A. Gromakova, et al.
Veröffentlicht: (2020)

The features of reproductive function in women with breast cancer
von: S. E. Ragimzade
Veröffentlicht: (2016)